SCAI

This channel contains news about the Society for Cardiac Angiography and Interventions (SCAI), including coverage of its annual meeting and links to recently released practice guidelines. SCAI is a leading resource in interventional cardiology and cath lab techniques and technologies. 
 

First study to compare safety and eficacy of clopidogrel and aspirin monotherapy beyond 12 months in high-risk PCI population
News | Cardiovascular Clinical Studies
Long-term Use of Clopidogrel Monotherapy Associated with Lower Patient Risk Compared to Aspirin Motherapy

May 20, 2022 — Results from a real-world study investigating safety and effectiveness of clopidogrel versus aspirin ...

Home May 20, 2022
Home
Multi-center study explores new treatment for heart failure patients with preserved and reduced ejection fraction
News | Heart Failure
No-implant Interatrial Shunt Device to Treat Heart Failure Patients Reveals Promising Multi-center Clinical Data

May 20, 2022 — Results from early clinical evaluation of the Alleviant System to treat heart failure patients with ...

Home May 20, 2022
Home
New Analysis Shows the Evolution of Intervention Techniques in Chronic Total Occlusion Patients
News | Chronic Total Occlusion (CTO)
International Chronic Total Occlusion Percutaneous Coronary Intervention Registry Finds Increasing Procedural Success

May 20, 2022 — A new analysis of PROGRESS-CTO (PROspective Global REgiStry for the Study of Chronic Total Occlusion ...

Home May 20, 2022
Home
Three years ago a study raised concerns that paclitaxel-coated devices may cause increased mortality in peripheral artery disease patients. However, numerous studies now show there is no risk of increased mortality. The most recent study is the SAFE-PAD study presented at SCAI22.
News | Peripheral Artery Disease (PAD)
New Longterm Data of Paclitaxel Devices Continues to Show No Increased Mortality Compared to Non-drug Coated Devices

May 20, 2022 — New long-term data from the Safety Assessment of Femoropopliteal Endovascular Treatment With PAclitaxel ...

Home May 20, 2022
Home
The Medtronic Harmony transcatheter pulmonary valve (TPV) system offers a less invasive treatment option for patients with a congenital heart defect irregularity in their right ventricular outflow tract (RVOT) that requires a pulmonary valve placement to restore valve function. 
News | Heart Valve Technology
First Intermediate to Long-term Study of the Harmony Transcatheter Pulmonary Valve System Validates Safety and Efficacy

May 19, 2022 — A study of 1-year outcomes in the largest cohort to date of Harmony transcatheter pulmonary valve (TPV) ...

Home May 19, 2022
Home
First multi-center, randomized controlled study provides the largest long-term evidence for the treatment of heavily calcified femoropopliteal lesions
News | Peripheral Artery Disease (PAD)
Disrupt PAD III Trial Demonstrates Safety and Effectiveness of Intravascular Lithotripsy for Peripheral Artery Calcification

May 19, 2022 — One year outcomes from the Disrupt PAD III Trial comparing intravascular lithotripsy (IVL) with a drug ...

Home May 19, 2022
Home
The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking clinical research at the Society for Cardiovascular Angiography & Interventions (SCAI) 2022 Scientific Sessions.
News | STEMI
International COVID-19 Registry Finds Significant Increased Risk of In-hospital Mortality for STEMI Patients with COVID-19 Compared to Pre-pandemic

May 19, 2022 — The latest analysis from The North American COVID-19 STEMI (NACMI) was presented today as late-breaking ...

Home May 19, 2022
Home
30-day findings from the DIPRA study demonstrate distal radial artery access poses no increased hand dysfunction risk
News | Radial Access
Novel Distal Radial Access for Cardiac Catheterization Shown as a Safe Strategy Compared to Conventional Radial Access

May 19, 2022 — Initial findings from the Distal versus Proximal Radial Artery Access for Cardiac Catheterization and ...

Home May 19, 2022
Home
After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) looks forward to welcoming more than 2,000 attendees to an exciting, fully live meeting in Atlanta, May 19-22.
News | SCAI
SCAI22 Scientific Sessions

May 10, 2022 — After two years of virtual meetings, the Society for Cardiovascular Angiography & Interventions (SCAI) ...

Home May 10, 2022
Home
Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were 25% lower in 2021 than in 2020, and no deaths occurred among patients who had been vaccinated against COVID-19, according to data presented at the American College of Cardiology’s 71st Annual Scientific Session.
News | STEMI
In-Hospital Deaths in STEMI Patients With COVID-19 Drop in 2021

April 6, 2022 – Deaths among hospitalized patients who had both COVID-19 and the most severe type of heart attack were ...

Home April 06, 2022
Home
Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced it has successfully completed enrollment in its phase 2 study of istaroxime in early cardiogenic shock caused by heart failure.
News | Pharmaceuticals
Windtree Completes Enrollment of Phase 2 Study of Istaroxime in Early Cardiogenic Shock

March 31, 2022 – Windtree Therapeutics, a biotechnology company focused on advancing multiple late-stage interventions ...

Home March 31, 2022
Home
People who have heart artery-opening procedures, called coronary artery revascularization, experience similar outcomes regardless of gender or race, thus the use of invasive heart procedures should not be limited among women and adults from diverse racial or ethnic groups, according to a new joint guideline from the American College of Cardiology and the American Heart Association, in partnership with the Society for Cardiovascular Angiography and Interventions.
News | Cardiovascular Business
American College of Cardiology, American Heart Association Issue Coronary Artery Revascularization Guideline

February 11, 2022 — People who have heart artery-opening procedures, called coronary artery revascularization ...

Home February 11, 2022
Home
Figure 1Recommended Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention. ∗While not marketed in the United States, DCBs are available for clinical use in Canada, with 1-3 months of DAPT recommended. DAPT = dual antiplatelet therapy; LD, limited data. Reprinted from Capodanno D, Alfonso F, Levine GN, Valgimigli M, Angiolillo DJ. ACC/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison. J Am Coll Cardiol. 2018;72(23 Pt A):2915-2931, with permission from
News | Womens Cardiovascular Health
SCAI Releases Expert Consensus on Gender-specific Considerations in Myocardial Revascularization

February 9, 2022 — A newly released expert consensus statement on sex-specific considerations in myocardial ...

Home February 09, 2022
Home
Videos | Cardiogenic Shock
VIDEO: Updates Made to the SCAI Cardiogenic Shock Classifications

Srihari Naidu, M.D., FACC, FAHA, FSCAI, is the director of both the cardiac cath labs and Hypertrophic Cardiomyopathy ...

Home November 16, 2021
Home
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.
Feature | Coronavirus (COVID-19) | By Dave Fornell, Editor
Cardiovascular Societies Support COVID-19 Vaccines for all Healthcare Workers 

July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all ...

Home July 30, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now